Apricus Biosciences Inc. | Mutual Funds
Mutual Funds that own Apricus Biosciences Inc.
Vanguard Extended Market Index Fund
172,054
0.73%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
113,371
0.48%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
98,832
0.42%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
87,966
0.38%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
41,618
0.18%
0
0%
07/31/2018
Vanguard Balanced Index Fund
39,973
0.17%
0
0%
07/31/2018
6,146
0.03%
0
0.01%
09/05/2018
3,611
0.02%
0
0%
06/30/2016
iShares Core S&P Total US Stock Market ETF
1,280
0.01%
0
0%
09/06/2018
BlackRock Master Extended Market Index Series
1,237
0.01%
0
0%
01/31/2018
| Address |
11975 El Camino Real
San Diego California 92130
United States
|
|
Employees
|
- |
| Website |
http://www.apricusbio.com |
| Updated |
09/14/2018 |
| Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. |
